Dong-Mei Zhang Selected Research

chan su (ChanSu)

2/2021	1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
4/2019	Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
1/2017	Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
7/2016	Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.
8/2014	Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
10/2012	Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Mei Zhang Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 09/2008
12	Inflammation (Inflammations) 08/2021 - 12/2010
12	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 04/2007
9	Type 2 Diabetes Mellitus (MODY) 03/2022 - 11/2009
9	Insulin Resistance 03/2022 - 01/2017
8	Chronic Hepatitis B 01/2022 - 10/2015
6	Myocardial Infarction 01/2015 - 01/2011
5	Breast Neoplasms (Breast Cancer) 05/2019 - 09/2008
5	Fibrosis (Cirrhosis) 01/2019 - 01/2015
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017 - 10/2009
5	Hypertension (High Blood Pressure) 01/2016 - 03/2013
4	Obstructive Sleep Apnea 02/2022 - 12/2017
4	Hyperuricemia 08/2015 - 10/2009
4	Heart Failure 01/2015 - 01/2013
3	Liver Diseases (Liver Disease) 12/2021 - 04/2007
3	Diabetes Complications 11/2021 - 06/2021
3	Hypertrophy 10/2021 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 02/2021 - 12/2016
3	Cardiotoxicity 11/2020 - 01/2017
3	Hypoxia (Hypoxemia) 09/2020 - 11/2012
3	Cardiomegaly (Heart Hypertrophy) 08/2020 - 02/2014
3	Neuroinflammatory Diseases 05/2019 - 01/2016
3	Infections 02/2018 - 11/2016
3	Lung Neoplasms (Lung Cancer) 07/2016 - 07/2009
3	Body Weight (Weight, Body) 05/2015 - 10/2012
3	Liver Neoplasms (Liver Cancer) 08/2014 - 10/2012
2	Asthma (Bronchial Asthma) 02/2022 - 03/2021
2	Apnea 02/2022 - 01/2018
2	Hepatitis B 01/2022 - 01/2018
2	Non-alcoholic Fatty Liver Disease 12/2021 - 12/2013
2	Kidney Diseases (Kidney Disease) 11/2021 - 06/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 06/2018
2	Proteinuria 10/2021 - 06/2018
2	Pelvic Pain 04/2021 - 01/2021
2	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 04/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2019 - 01/2016
2	Reperfusion Injury 05/2018 - 01/2011
2	Dementia (Dementias) 01/2017 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2016
2	Cardiac Arrhythmias (Arrythmia) 07/2016 - 01/2013
2	Renovascular Hypertension (Goldblatt Syndrome) 01/2016 - 09/2014

Drug/Important Bio-Agent (IBA)

11	FructoseIBA 10/2021 - 10/2009
8	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
6	bufadienolideIBA 02/2021 - 06/2013
6	chan su (ChanSu)IBA 02/2021 - 10/2012
6	BufanolidesIBA 11/2020 - 10/2012
6	CytokinesIBA 01/2020 - 02/2014
6	Proteins (Proteins, Gene)FDA Link 06/2018 - 07/2011
5	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 06/2013
5	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 11/2009
5	arenobufaginIBA 11/2018 - 06/2013
4	Glucagon (Glukagon)FDA Link 03/2022 - 11/2020
4	AntigensIBA 01/2022 - 10/2009
4	C-PeptideIBA 06/2021 - 03/2008
4	LipidsIBA 06/2021 - 12/2004
4	InflammasomesIBA 05/2018 - 01/2015
4	AntioxidantsIBA 02/2018 - 05/2009
4	Adenosine Triphosphate (ATP)IBA 07/2017 - 05/2013
3	Interleukin-6 (Interleukin 6)IBA 02/2022 - 12/2013
3	Small Interfering RNA (siRNA)IBA 10/2021 - 01/2015
3	Insulin (Novolin)FDA Link 05/2021 - 01/2017
3	Angiotensin IIIBA 08/2020 - 03/2013
3	Hepatitis B e AntigensIBA 01/2020 - 10/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 06/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 01/2016
3	bufalinIBA 07/2016 - 10/2012
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 12/2013
3	AcidsIBA 05/2015 - 10/2006
3	Messenger RNA (mRNA)IBA 05/2015 - 07/2011
3	salicylhydroxamic acid (SHAM)IBA 12/2013 - 07/2011
3	pheophorbide aIBA 07/2009 - 04/2007
2	C-Reactive ProteinIBA 02/2022 - 01/2018
2	nasIBA 01/2022 - 12/2017
2	Biological ProductsIBA 12/2021 - 05/2021
2	CreatinineIBA 11/2021 - 10/2009
2	Adenosine DeaminaseIBA 08/2021 - 05/2021
2	AdipokinesIBA 06/2021 - 01/2018
2	EnzymesIBA 05/2021 - 01/2016
2	Therapeutic UsesIBA 01/2021 - 01/2016
2	ProdrugsIBA 11/2020 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 08/2020 - 01/2015
2	Tenofovir (Viread)FDA Link 01/2020 - 01/2020
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020 - 01/2019
2	entecavir FDA Link 01/2020 - 01/2020
2	LipopolysaccharidesIBA 05/2019 - 12/2015
2	Amphibian VenomsIBA 04/2019 - 06/2013
2	pterostilbeneIBA 01/2019 - 01/2019
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2019 - 05/2009
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 12/2017
2	InterferonsIBA 01/2018 - 11/2016
2	morinIBA 01/2017 - 12/2013
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 12/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 12/2013
2	Allopurinol (Remid)FDA LinkGeneric 01/2016 - 10/2009

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2011
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2021 - 04/2007
8	Drug Therapy (Chemotherapy) 07/2017 - 03/2009
3	Aftercare (After-Treatment) 02/2022 - 07/2011
2	Surgical Instruments (Clip) 01/2016 - 09/2014